URAC Measurement-Based Care Designation Consulting — Integral Healthcare Solutions

Last updated: April 2026

IHS guides behavioral health organizations through every phase of URAC's Measurement-Based Care (MBC) Designation — from gap assessment through standards documentation, mock review, and designation submission. The MBC Designation layers onto existing URAC accreditation to demonstrate systematic, validated outcomes tracking for mental health and substance use disorder (MH/SUD) populations. Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — leads IHS's URAC consulting practice.

What Is the URAC Measurement-Based Care Designation?

Measurement-Based Care (MBC) is the systematic practice of administering validated patient self-assessment instruments at every clinical encounter, tracking symptom severity over time, and using that data to drive treatment decisions. The evidence base is robust: MBC produces a 20–60% improvement in clinical outcomes compared to care delivered without structured symptom tracking (URAC). Despite this, fewer than 20% of behavioral health practitioners implement MBC in routine practice — a gap driven by workflow barriers, unfamiliarity with patient-reported outcome measures, and limited organizational infrastructure.

URAC's MBC Designation is a formal recognition program that allows a URAC-accredited or certified organization to demonstrate excellence in MBC implementation. It consists of a focused set of standards — not a full-length accreditation program — that evaluate whether an organization has embedded systematic symptom tracking, data-informed care planning, and MBC-driven quality improvement into its operations. The Designation is elective: it sits on top of an existing URAC accreditation or certification, adding a demonstrable layer of clinical rigor for payers, purchasers, and regulators evaluating behavioral health network quality.

What Measurement-Based Care Looks Like in Practice

Under an MBC-compliant model, every patient encounter in a behavioral health program involves a validated self-assessment. The patient completes a standardized instrument — PHQ-9 for depression, GAD-7 for anxiety, AUDIT-C for alcohol use, DAST-10 for drug use, or a condition-appropriate equivalent — before or at the start of each visit. Results are scored, trended over time, and used by the clinician to evaluate whether the current treatment plan is producing the expected response.

When scores plateau or worsen, MBC creates a structured prompt to change the plan — adding a medication, adjusting dosage, introducing a different therapeutic modality, or escalating to a higher level of care. When scores reach remission thresholds, MBC flags that milestone for documentation and care planning purposes. This is not informal — URAC's standards require that symptom severity changes be classified into clinically meaningful categories, and that the organization's clinical infrastructure support that classification at scale.

Why URAC Created the MBC Designation

The MBC Designation is part of URAC's broader Path Forward agenda — an initiative to align accreditation with measurable health outcomes rather than process compliance alone. Mental health and substance use disorder care historically lacked the systematic outcome tracking that physical health disciplines take for granted. A patient with diabetes has lab values measured at every visit. A patient with depression historically might not have a validated severity score documented for months at a time.

URAC's Designation provides a formal credentialing signal that an organization has closed that gap — that behavioral health services delivered by a URAC-designated organization are tracked, measured, and adjusted based on evidence at the patient level.

Who Needs the URAC MBC Designation?

The MBC Designation is relevant to any URAC-accredited organization operating in the behavioral health space. The most common candidates are:

  • Managed Behavioral Health Organizations (MBHOs) — administering behavioral health benefits for health plans or employers, increasingly required by payer contracts to demonstrate MBC infrastructure
  • Health plans with behavioral carve-in models — integrating behavioral health within a URAC Health Plan Accreditation framework and seeking to demonstrate outcomes rigor to purchasers
  • Integrated behavioral health delivery systems — operating collaborative care models where primary care providers deliver psychiatric collaborative care and payers require MBC documentation
  • Outpatient behavioral health organizations — seeking market differentiation from commercial payers, employer coalitions, or state behavioral health authorities that evaluate network quality
  • Employee Assistance Programs (EAPs) — accredited under URAC's EAP Accreditation and adding MBC as a demonstrable outcomes capability for employer clients
  • Telehealth behavioral health platforms — URAC-accredited telehealth organizations expanding into behavioral health delivery with payer-facing MBC documentation

Market pressure is accelerating. The National Alliance of Healthcare Purchaser Coalitions has highlighted URAC's MBC Designation as a specific mechanism for purchasers to evaluate behavioral health network quality (National Alliance). Employers and coalitions are beginning to require MBC evidence from their behavioral health contractors — making the Designation a pre-competitive credential in some markets and a contractual requirement in others.

The URAC MBC Designation Process

The MBC Designation is an elective add-on to existing URAC accreditation. Your organization must hold a current URAC accreditation or certification to be eligible. The Designation process follows URAC's standard designation framework — gap assessment, standards documentation, application submission, and URAC review — but is narrower in scope than a full accreditation application. Here is how IHS structures the engagement.

Phase 1: Eligibility Confirmation and MBC Gap Assessment (Weeks 1–4)

IHS begins by confirming your organization holds a current URAC accreditation or certification and identifying which specific URAC program the Designation will attach to. We then conduct a structured gap assessment against each MBC Designation standard, evaluating your current clinical infrastructure across four dimensions: assessment tool selection and deployment, symptom severity classification and documentation, care plan integration, and MBC quality improvement infrastructure.

The gap assessment produces a remediation roadmap with findings ranked by severity and implementation complexity. Many organizations have informal MBC practices already in place — the gap is typically in documentation, classification rigor, and QI integration rather than in assessment tool use itself.

Phase 2: Standards Documentation and Policy Development (Weeks 4–12)

IHS provides policy and procedure templates for each MBC Designation standard. This includes: clinical assessment protocols specifying tool selection, administration frequency, and scoring procedures; symptom severity classification frameworks with threshold definitions for clinically meaningful change, response, and remission; care plan integration policies requiring documented linkage between assessment scores and treatment decisions; escalation protocols for patients whose scores indicate non-response or clinical deterioration; and MBC quality improvement frameworks integrating outcome data into the organization's existing QI program.

Your team adapts these templates to your specific patient population, service lines, and EHR infrastructure. IHS advises on tool selection (proprietary vs. freely available instruments), EHR workflow design, and staff training requirements. The PHQ-9 and GAD-7 are freely available and widely validated — adoption of nonproprietary instruments aligned with the MBC goals typically minimizes both implementation cost and URAC documentation burden.

Phase 3: Mock Standards Review (Weeks 12–16)

IHS conducts a mock review of your MBC documentation against each Designation standard, simulating URAC's review process. We examine clinical assessment records for documentation completeness, evaluate symptom severity classification consistency, and test whether your care plan documentation traces assessment data to treatment decisions. Gaps identified in mock review are corrected before formal application — this is where most preventable deficiencies are caught.

Phase 4: Application Submission and URAC Review

IHS prepares and supports submission of the formal MBC Designation application to URAC, including all required documentation, policy evidence, and supporting materials. If URAC issues requests for additional information during review, IHS provides direct response support. URAC reviews the application against Designation standards and issues the MBC Designation decision.

Internal Resource Requirements

The MBC Designation requires dedicated clinical and operational staff to implement and sustain the program. You will need a clinical lead responsible for tool selection and assessment protocol oversight, EHR or technology staff to integrate assessment workflows into the clinical platform, quality improvement staff to incorporate MBC data into existing QI reporting, and clinical supervisors to monitor assessment compliance and documentation quality. IHS does not replace your internal team — we ensure your team is building against the correct standards from the first day of implementation.

Common MBC Designation Implementation Challenges

IHS has identified recurring patterns in how behavioral health organizations struggle to implement MBC practices that meet URAC's standards. These are not hypothetical gaps — they are the gaps that show up in documentation reviews and mock assessments. Knowing them in advance is the difference between a clean application and a request for remediation.

1. Assessment Tool Administration Gaps

The standard requires: Validated symptom rating scales administered at each clinical encounter, producing reliable symptom severity data.

How organizations fail: Assessments administered at intake and annually — not at each encounter. Tools vary by clinician preference rather than standardized organizational protocol. No mechanism exists to flag missed assessments.

How IHS prevents it: Our gap assessment evaluates your current assessment cadence and identifies the workflow intervention points needed to achieve encounter-level compliance. We provide protocol templates and EHR flag documentation requirements.

2. Symptom Severity Classification Inconsistency

The standard requires: Classification of symptom severity changes into clinically meaningful categories, with guidelines enabling identification of patients achieving remission.

How organizations fail: Scores are recorded but not classified. Clinicians apply informal interpretation without standardized thresholds. The organization cannot produce aggregate data on response rates or remission rates because classification is not systematized.

How IHS prevents it: We provide classification framework templates with instrument-specific thresholds for response, partial response, non-response, and remission — aligned with the published psychometric evidence for each tool.

3. Care Plan Linkage Failures

The standard requires: Assessment data to inform individualized care plans and enable identification of patients who have achieved remission.

How organizations fail: Assessment scores are collected in one part of the clinical record and care plans exist in another, with no documented connection. Clinicians use scores informally but no documentation trail connects score trends to treatment decisions.

How IHS prevents it: Our policy templates require explicit documentation of the relationship between assessment scores and treatment plan decisions at each review point. We advise on EHR template design to make linkage documentation a required field rather than an optional narrative.

4. Quality Improvement Integration Gaps

The standard requires: Incorporation of MBC into performance process measures, outcomes evaluation, and quality improvement efforts.

How organizations fail: Clinical MBC data is never aggregated. The QI program continues to track process measures (appointment adherence, no-show rates) without incorporating MBC outcome measures. The organization has no mechanism for reporting on response or remission rates at the program level.

How IHS prevents it: We integrate MBC outcome reporting into your existing QI program structure, define MBC-specific performance measures, and provide QI report templates that incorporate aggregate assessment data.

5. Staff Training Documentation

The standard requires: Evidence that clinical staff are trained on assessment tool administration, scoring, and interpretation.

How organizations fail: Training occurs informally. No training records exist. New staff are oriented verbally but there is no documented competency assessment or training curriculum.

How IHS prevents it: We provide training framework templates including curriculum outlines, competency assessment criteria, and documentation requirements that create an auditable training record.

Why IHS for URAC MBC Designation

Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — founded IHS on the premise that URAC consulting requires insider knowledge of how URAC standards are written, interpreted, and applied. The MBC Designation is a clinically complex program that sits at the intersection of behavioral health operations, quality improvement infrastructure, and URAC standards compliance. IHS brings all three.

What Sets IHS Apart

  • Direct URAC institutional knowledge — Thomas G. Goddard served as URAC's COO and General Counsel before founding IHS, giving IHS a standards interpretation depth that no other consulting firm can claim
  • Behavioral health operations expertise — IHS consults on URAC Health Plan, URAC Case Management, URAC Utilization Management, and URAC Behavioral Health programs — the accreditations most likely to host an MBC Designation add-on
  • Standards documentation discipline — URAC reviews documentation, not intentions. IHS templates are built to the evidentiary standard URAC reviewers apply, not to what seems reasonable internally
  • EHR-neutral workflow design — IHS advises on MBC workflow architecture that is platform-agnostic, giving your technology team the requirements rather than prescribing a vendor solution
  • Quality improvement integration — IHS designs MBC QI integration into your existing URAC-compliant QI program, so the Designation adds to your accreditation posture rather than creating a parallel compliance silo

Adjacent IHS Services

The MBC Designation attaches to an existing URAC accreditation. If your organization is simultaneously pursuing or renewing URAC accreditation, IHS can coordinate both engagements. IHS provides consulting for URAC Health Plan Accreditation, URAC Case Management Accreditation, URAC Utilization Management Accreditation, and URAC Behavioral Health Accreditation. Coordinating the base accreditation and MBC Designation in a single engagement reduces documentation redundancy and shortens the overall timeline.

Frequently Asked Questions

What is the URAC Measurement-Based Care Designation?

URAC's MBC Designation is an elective add-on to existing URAC accreditation or certification. It is a focused set of standards — not a full accreditation program — that recognizes organizations demonstrating systematic use of validated patient self-assessment tools to track symptom severity and inform treatment decisions for MH/SUD populations. See the full MBC Designation FAQ for detailed answers to 13 common questions.

Does my organization need URAC accreditation before pursuing the MBC Designation?

Yes. The MBC Designation is an elective add-on to URAC accreditation or certification — it cannot be pursued as a standalone credential. Your organization must hold a current URAC accreditation or certification before applying for the Designation. IHS can coordinate base accreditation and Designation pursuits in a single engagement if your organization is simultaneously pursuing both.

What tools are used in measurement-based care?

Common validated instruments include: PHQ-9 (depression), GAD-7 (generalized anxiety disorder), AUDIT-C (alcohol use), DAST-10 (drug use), PCL-5 (PTSD), Columbia Suicide Severity Rating Scale (suicide risk), and condition-specific alternatives. URAC's standards require validated, reliable instruments — the organization selects tools appropriate to its patient population. Freely available instruments such as the PHQ-9 and GAD-7 are generally preferable because they eliminate licensing cost and are widely supported in EHR platforms.

How does the MBC Designation benefit my organization?

The Designation provides a formal signal to payers, employers, and purchasers that your behavioral health program uses systematic, validated outcomes tracking — not just process compliance. As purchaser coalitions and payers increasingly evaluate network quality based on outcomes evidence, the MBC Designation distinguishes your organization in contracting conversations. In some payer relationships, MBC documentation is becoming a contractual requirement rather than a differentiator.

What outcomes does measurement-based care produce?

Research consistently shows 20–60% better outcomes in programs implementing MBC compared to non-MBC care (URAC). A large-scale implementation study found approximately 23.5% relative improvement on combined PHQ-9 and GAD-7 measures following MBC implementation, with 95% of clinicians demonstrating improved documentation behaviors (Frontiers in Health Services, 2025). Discharge rates improved 22–29% in MBC groups compared to non-MBC groups, suggesting MBC correlates with treatment completion.

Related Resources

Ready to Get Started?

Schedule a no-obligation consultation with IHS. We will assess your current MBC infrastructure, confirm your URAC accreditation eligibility for the Designation, and give you a clear roadmap to submission.

Schedule a Free Discovery Session